Drug Safety and Risk Management Advisory Committee

Questions to the Committee


Question 1: FDA/NABP Study Findings

What additional analyses of the FDA/NABP/Svarstad study do committee members suggest to answer remaining questions about the adequacy of patient information?

Question 2: Additional Research Needs

What additional research does the committee recommend to document the areas and means for improving written patient medication information handed out by pharmacists? The committee may wish to consider the following:

Question 3: Suggested Actions to Achieve 2006 Goals

What actions do committee members suggest to improve consumer medication information to meet the 2006 goal of 95% of new prescriptions dispensed being accompanied by useful written information? Please provide opinion on relative importance (low, medium, high) and time frame for implementation (immediate, near-term, longer- term)

Sample topics that may be addressed include: